This retrospective cohort study compared cumulative incidences of antihypertensive drug discontinuation at 8 and 48 weeks in two public primary care clinics in Hong Kong, including 2531 patients who newly received a first-ever antihypertensive monotherapy during the period 1990-2002. From clinical patient records, thiazide diuretics had significantly lower discontinuation rates (0.00%) as compared to all other drug classes at 8 weeks in both young males (range: 5.4-10.8% in other classes, P ¼ 0.016) and young females (range: 3.9-9.6% in other classes, Po0.001), while at 48 weeks calcium channel blockers (CCBs) showed the highest discontinuation rate (23.0%, 95% CI 17.0%, 29.0%) significantly different from b-blockers (14.4%, 95% CI 10.9%, 17.9%, P ¼ 0.011) and thiazide diuretics (13.1%, 95% CI 8.6%, 17.6%, P ¼ 0.010) in young females (overall P ¼ 0.041). This finding highlights cautions of higher rates of discontinuing CCBs in the long term, and the lower short-term discontinuation rates of thiazides than other drug classes, which strengthens the recommendations from international authorities such as the British Hypertension Society as a best first-line drug for Chinese patients.
Both mortality and morbidity associated with hypertension can be decreased given the consistent drug treatment, 1,2 but medication persistence must be matched by tolerability of prescriptions.
In the HANE (Hydrochlorothiazide, Atenolol, Nitrendipine and Enalapril) study, nitredipine (a CCB) was reported to have a higher rate of dropouts. 3 A longer duration of persistence has been regarded as a proxy measure of tolerability. 4 Nevertheless, it is important to note that guidelines on the use of antihypertensive drugs are based almost exclusively on studies conducted among Caucasian subjects. [5] [6] [7] [8] [9] Owing to ethnic differences, it is unknown whether findings in the existing literatures based on Caucasian subjects can be safely generalized to Chinese patients. Even small ethnic differences in its optimum management have large implications for health resources. 10 There is a paucity of data on profiles of antihypertensive discontinuations among ethnic Chinese. This study compared the short-and long-term cumulative incidences of drug discontinuation of the major antihypertensive drug classes commonly prescribed in primary care in a Chinese population, using a clinical database containing comprehensive computerized patient information. A previous study has evaluated this database and reported a high level of data completeness in patient demographics (100%) and drug prescription details (99.98%) (unpublished data). All antihypertensive drug-naïve patients who attended two primary care clinics newly started their first-ever antihypertensive drug prescription belonging to any of the four drug classes (thiazide diuretics, b-blockers (BBs), CCBs and angiotensin converting enzyme inhibitors) during the study period 1990-2002 were eligible participants. Only patients diagnosed as having uncomplicated hypertension, as evidenced by the presence of the International Code of Primary Care (ICPC) K86 in the computer system, were included. Exclusion criteria include the concomitant use of any chronic medications: the prescription of more than one class of antihypertensive and change in drug dosage or frequency within 48 weeks after the first-ever antihypertensive monotherapy. Sample size was calculated based on the smallest difference in proportions of discontinuation among drug groups from a meta-analysis of drug-drug comparison trials. 11 Only proportions of discontinuation between thiazides and BBs showed significant difference and the smallest effect size exists (5 vs 10%). Setting a ¼ 0.05 and b ¼ 0.20, 434 patients per drug group were required to detect statistically significant difference. Discontinuation is defined as the absence of a refill prescription on all subsequent antihypertensive drug visits without the issuance of another class of antihypertensive drugs. The cumulative incidences of discontinuation for each drug group were compared by w 2 tests of homogeneity, followed by six pairwise comparisons among the four drug groups if the initial test yields Po0.05.
A total of 2531 eligible patients were included (Supplementary Information). The participants had a mean (±standard deviation) age of 61 (±12) years. At 8 weeks, none of the thiazide diuretic prescriptions were discontinued in young male and young female patients (Table 1) . For the diuretic group, all pairwise comparisons with other drug groups were highly significant among young patients (Po0.001). There was no statistical significance among drug groups in the elderly male (P ¼ 0.541) and elderly females (P ¼ 0.135). At 48 weeks, CCBs had the highest discontinuation rate (23.0%, 95% CI 17.0%, 29.0%) in the young female patients (P ¼ 0.041). The cumulative incidence of CCB discontinuation was statistically higher than thiazide diuretics (13.1%, 95% CI 8.6%, 17.6%, P ¼ 0.010) and BBs (14.4%, 95% CI 10.9%, 17.9%). For other age-and genderspecific groups, there were no differences in discontinuation rates at 48 weeks.
Our findings showed that thiazide diuretics had the lowest discontinuation rate in the short term among the young populations. Also the discontinuation rates of CCBs were significantly higher than thiazide diuretics and BBs in the long term among young female patients. The preliminary result of high discontinuation rates of CCBs advised against CCB use as a first-line agent in this patient group, although the underlying reasons were to be evaluated.
At present only the HANE study 4 evaluated the discontinuation rates of antihypertensive drugs at 8 and 48 weeks. They found the lowest discontinuation rate of thiazide (6.5%) at 8 weeks as compared to BBs (7.4%), CCBs (14.2%) and angiotensin converting enzyme inhibitors (10.5%). In addition, the discontinuation rate of CCBs was the highest at 48 weeks (22.0%) as compared to other drug groups (range: 13.0-14.5%). Our results are similar to the HANE study as concerns the lowest discontinuation rates of diuretics at 8 weeks among the young males and females and the higher discontinuation rates of CCBs at 48 weeks among young female patients. The absolute figures of the latter were also similar between our result in the young female group and that of the HANE study.
This study included patients having uncomplicated hypertension and being started their first-ever antihypertensive monotherapy without concomitant intake of other chronic medications. This strengthens the result validity as this inclusion criteria make discontinuation likely to be attributable to the firstever prescription. The limitations of this study should be addressed. First, we regarded the ICPC code as the gold standard of diagnosis of uncomplicated hypertension, and the absence of other prescriptions in the clinical database as the absence of concomitant chronic drug use. Nevertheless, given the relatively simple and straightforward diagnosis of hypertension and the ability of our database to record all medications, we believed this bias to be minimal. We are also unable to evaluate the cause of discontinuation and the profiles of side effects from this study, which should be better addressed by survey-based studies.
In light of the present findings, therefore, the prescription of thiazide diuretics as the first-line agent might be justified also in Chinese patients given its excellent short-term persistence profiles among other antihypertensive drug classes, especially among young patients. However, physicians should bear in mind that longer-term discontinuation rate for thiazide diuretics could be high, especially in the elderly males where the discontinuation rates after 48 weeks were two (BBs) to three times (CCBs and angiotensin converting enzyme inhibitors) higher for diuretics. Cautions should also be practiced when CCBs were prescribed to Chinese patients, especially due to its possible adverse effects in a longer time frame.
Further studies should be targeted towards evaluating the cost-effectiveness and pharmacokinetic aspects of thiazides diuretics to ascertain its place as first-line agent among Chinese populations.
